D-Serine in the Treatment of Psychosis

D-Serine in the Treatment of Psychosis
复制标题

D-丝氨酸治疗精神病

DOI:
10.1007/978-3-319-56015-1_391-1
复制
发表时间:
2021
期刊:
NeuroPsychopharmacotherapy
影响因子:
--
通讯作者:
Masakazu Umino
Masakazu Umino
中科院分区:
--
文献类型:
--
作者:
Toru Nishikawa;Asami Umino;Masakazu Umino

文献摘要

参考文献

相似文献

本章旨在提供有关D-丝氨酸的基本信息及其在目前用于精神分裂症的抗精神病药物的辅助药物治疗中的应用。第一部分介绍了D-丝氨酸的化学结构和代谢特点、药理及药代动力学。特别解释了D-丝氨酸与由GluN1/GluN2亚基组成的甲基-D-天冬氨酸型谷氨酸受体的相互作用,以及D-丝氨酸对包括GluN1/GluN3亚基和GluD2型谷氨酸受体的影响。连续的章节描述了D-丝氨酸用于精神分裂症和其他神经精神疾病药物治疗的临床适应症,并总结了添加D-丝氨酸治疗精神分裂症和分裂情感障碍的临床试验及其对这些疾病现有的抗精神病药物耐药症状的疗效。此外,还列出了这些试验的Meta分析的综述和结论。最后一节提到了D-丝氨酸临床治疗过程中的不良事件、耐受性和安全性。
This chapter is intended to provide fundamental information about D-serine and its application to adjunctive pharmacotherapy with currently used antipsychotics for schizophrenia. In the first sections, the chemical structures and features of the metabolism, pharmacology, and pharmacokinetics of D-serine are introduced. In particular, the interaction between D-serine and theN-methyl-D-aspartate-type glutamate receptor (NMDA receptor) consisting of GluN1/GluN2 subunits, which is the basis for the therapeutic action of D-serine on schizophrenia, is explained, and the effects of D-serine on the NMDA receptor including GluN1/GluN3 subunits and the GluD2-type glutamate receptor are also discussed. The consecutive sections describe the clinical indications of D-serine under investigation for the pharmacotherapy of schizophrenia and other neuropsychiatric disorders, and summarize the clinical trials of add-on D-serine in schizophrenia and schizoaffective disorder and their efficacy for presently available antipsychotic-resistant symptoms in these disorders. Furthermore, the overviews and conclusions of the meta-analyses of these trials are listed. The last sections mention the adverse events, tolerability, and safety during the clinical treatment with D-serine.
DOI: 10.1046/j.1471-4159.1997.69010399.x
发表时间: 1997-07
影响因子: 4.7
作者:
M. Matoba;U. Tomita;T. Nishikawa
通讯作者: M. Matoba;U. Tomita;T. Nishikawa
DOI: 10.1001/archpsyc.62.11.1196
发表时间: 2005-11-01
影响因子: --
作者:
Lane, HY;Chang, YC;Tsai, GE
通讯作者: Tsai, GE
啮齿类动物内侧前额皮质细胞外 D-丝氨酸浓度的 GABAA 受体强直控制的证据
DOI: --
发表时间: 2017
影响因子: 4.8
作者:
A. Umino;Sayuri Ishiwata;H. Iwama;T. Nishikawa
通讯作者: T. Nishikawa
DOI: 10.1001/archpsyc.1988.01800330013001
发表时间: 1988-09
影响因子: --
作者:
J. Kane;G. Honigfeld;J. Singer;H. Meltzer
通讯作者: J. Kane;G. Honigfeld;J. Singer;H. Meltzer
DOI: 10.1016/j.schres.2017.02.027
发表时间: 2018-01-01
影响因子: 4.5
作者:
Kantrowitz, Joshua T.;Epstein, Michael L.;Javitt, Daniel C.
通讯作者: Javitt, Daniel C.